Data Year:

For its 2024 fiscal year, PROCEPT BIOROBTCS CORP, listed the following executives on its annual proxy statement to the SEC

Equity
Cash Compensation
Other
Fiscal Year Ended in 2024
Name And Title Total Compensation Pay Rank By Title In MFG Durable industry
Kevin Waters
EVP, Chief Financial Officer
Total Compensation $2,187,988 View details Pay Rank By Title In MFG Durable industry #338 View more
Hisham Shiblaq
EVP, Chief Commercial Officer
Total Compensation $3,587,208 View details Pay Rank By Title In MFG Durable industry #81 View more
Reza Zadno Ph.D.
President & Chief Executive Officer
Total Compensation $6,521,876 View details Pay Rank By Title In MFG Durable industry #326 View more
Alaleh Nouri
EVP, Chief Legal Officer & Corporate Secretary
Total Compensation $2,653,751 View details Pay Rank By Title In MFG Durable industry #53 View more

The charts on this page feature a breakdown of the total annual pay for the top executives at PROCEPT BIOROBTCS CORP as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. PROCEPT BIOROBTCS CORP income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. PROCEPT BIOROBTCS CORP annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Kevin Waters
EVP, Chief Financial Officer
Total Cash $758,100 Equity $1,423,888 Other $6,000 $2,187,988
Hisham Shiblaq
EVP, Chief Commercial Officer
Total Cash $750,250 Equity $2,836,958 Other $0 $3,587,208
Reza Zadno Ph.D.
President & Chief Executive Officer
Total Cash $1,311,550 Equity $5,210,326 Other $0 $6,521,876
Alaleh Nouri
EVP, Chief Legal Officer & Corporate Secretary
Total Cash $683,720 Equity $1,964,031 Other $6,000 $2,653,751
For its 2024 fiscal year, PROCEPT BIOROBTCS CORP, listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
Reza Zadno Ph.D. CEO Pay $6,521,876 Median Employee Pay $170,462 CEO Pay Ratio 38:1
For its 2024 fiscal year, PROCEPT BIOROBTCS CORP, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
Amy Dodrill Total Cash $248,887
Antal Desai Total Cash $243,887
Colby Wood Total Cash $16,319
Elisabeth Little Total Cash $250,316
Frederic Moll, M.D. Total Cash $255,966
Larry Wood Total Cash $537,421
Mary Garrett Total Cash $241,387
Taylor Harris Total Cash $251,387
Thomas Krummel, M.D. Total Cash $149,651
Thomas M. Prescott Total Cash $355,616
Browse Board of Directors By First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Executives by First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Companies by Company Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

Use of Data / Disclaimer

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

What is a proxy statement?

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.